RT-PCR FOR H1N1

The RT‑PCR test for H1N1 detects influenza A (H1N1) viral RNA by converting RNA to DNA (reverse transcription) and amplifying specific gene segments with PCR. A nasal or throat swab is collected; laboratory analysis provides highly sensitive and specific results, typically within hours to a day. It’s the preferred diagnostic method for confirming active H1N1 infection and guiding treatment.

Costs vary by country and provider. Public-health or clinic testing is often free or covered by insurance; private lab influenza PCR tests generally range from about $50–$200 (≈£40–£150 or ₹2,000–₹5,000). Comprehensive multiplex respiratory PCR panels cost more, commonly $100–$300. Prices depend on location, multiplex use, and subsidies—check local labs or clinics for exact fees.

Flu RT-PCR is a molecular laboratory test that detects and amplifies influenza viral RNA from respiratory samples (nasal or throat swabs). It identifies influenza A and B with high sensitivity and specificity, typically producing results within hours to a day. Clinicians use it to confirm infection, guide antiviral treatment, and support infection‑control and surveillance decisions.

The RT‑PCR (reverse transcription–polymerase chain reaction) test detects active infections from RNA viruses by converting viral RNA to DNA and amplifying specific genetic sequences. It’s used to diagnose infections (e.g., COVID‑19, influenza), confirm cases, guide treatment and isolation, and support public-health surveillance and outbreak tracing. It’s highly sensitive and widely used for clinical diagnosis and epidemiological testing.

If you test positive for H1N1: stay home and isolate to avoid spreading it; rest, drink fluids, and use fever reducers as needed. Antiviral treatment (e.g., oseltamivir) is recommended, especially for high‑risk people or severe illness — contact your healthcare provider promptly. Monitor for worsening (difficulty breathing, chest pain, confusion, high fever) and seek emergency care if these occur. Notify close contacts and follow public health advice.

Yes. RT‑PCR detects viral RNA by converting it to DNA and amplifying specific genetic sequences, allowing sensitive identification of infection. It indicates presence of viral genetic material but does not confirm live, infectious virus. Accuracy depends on timing, sample quality, and laboratory technique, so false negatives or positives can occur. Quantitative RT‑PCR can estimate viral load to help assess infection.